Soficitinib
Soficitinib (Compound 20) is a selective inhibitor targeting tyrosine kinase 2 (TYK2) and Janus kinase 2 (JAK2) with an IC50 values of 0.5 nM and 1.2 nM, respectively. Soficitinib is promising for research of autoimmune diseases (e.g., psoriasis, rheumatoid arthritis) and inflammatory diseases[1].
Product Specifications
CAS Number
[2574524-67-5]
UNSPSC
12352005
Target
JAK
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Field of Research
Inflammation/Immunology
Smiles
C[C@]12[C@](CN(C2)C(CC#N)=O)([H])CN(C3=NC(NC4=CN(C)N=C4)=NC=C3Cl)C1
Molecular Formula
C18H21ClN8O
Molecular Weight
400.87
References & Citations
[1]Heterocyclic compound, preparation method and application thereof in medicine and pharmacology. CN112142743A. 2020-12-29.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6340240-01 0.2 mL
RAP1A, CT (RAP1A, KREV1, Ras-related protein Rap-1A, C21KG, G-22K, GTP-binding protein smg p21A, Ras-related protein Krev-1) (AP)
Sign In for Pricing
View Details MBS6340240-02 5x 0.2 mL
RAP1A, CT (RAP1A, KREV1, Ras-related protein Rap-1A, C21KG, G-22K, GTP-binding protein smg p21A, Ras-related protein Krev-1) (AP)
Sign In for Pricing
View Details MBS6160264-01 0.1 mL
PUF60 (Poly(U)-binding-splicing Factor PUF60, 60kD Poly(U)-binding-splicing Factor, FUSE-binding Protein-interacting Repressor, FBP-interacting Repressor, FIR, Ro-binding Protein 1, RoBP1, ROBPI, Siah-binding Protein 1, SIAHBP1, Siah-BP1) (PE)
Sign In for Pricing
View Details